An investigation into the Maryland Medical Cannabis Commission found “no evidence of bias or undue influence in the 2019 license application review process” and that former Del. Cheryl Glenn did not influence the process, despite her pleading guilty in January to accepting more than $33,000 in bribes.
A report released Thursday and written by the Zuckerman Spaeder LLP law firm said several allegations of bias leveled against the commission, including a claim that its former executive director was related to an applicant, were unfounded.
As for Glenn, while she admitted to accepting bribes in exchange for votes or supporting legislation related to the industry she helped build, the investigation found they did not affect the application review process.
“Although these revelations were troubling, Delegate Glenn’s communications with [the commission] were quite limited, and we found no evidence that she improperly influenced the review process,” the law firm wrote.
Read more at baltimoresun.com